ClearTrial Launches Study Consult Service as Extension to its Clinical Trial Software

ClearTrial's Study Consult Service(tm) helps Biopharmaceutical companies find cost-savings, accelerate timelines, and ensure achievability in clinical trial planning and outsourcing

Oakbrook Terrace, IL (PRWEB) September 14, 2006 -- ClearTrial, LLC announced today the launch of its Study Consult Service™ (SCS), a service offering that is an extension of ClearTrial’s clinical trial software which helps biopharmaceutical companies and clinical research organizations (CROs) to plan, budget, outsource, and optimize the operational design of clinical trials.

The objective of ClearTrial’s Study Consult Service™ (SCS) is to identify cost-saving opportunities in the operational design of a clinical trial, accelerate clinical study timelines, and ensure achievability of clinical study plans. During a Study Consult, ClearTrial provides a 3rd party, objective review of the operational study design, and uses the ClearTrial software to identify efficiency opportunities.

“ClearTrial’s staff has enormous depth of clinical operations and outsourcing experience,” said Michael Soenen, Managing Partner and Chief Operating Officer at ClearTrial. “And while our customers benefit from that experience by using our software, they can now maximize their software investment, and gain new perspective, by engaging a ClearTrial clinical professional to perform a Study Consult.”

ClearTrial also uses its software to present its findings to its customers, typically via a web meeting. Some of ClearTrial’s customers have already achieved notable results from the Study Consult Service™.

“ClearTrial’s Study Consult Service™ very quickly showed us a more efficient operational approach to a phase II oncology study that resulted in a cost savings of $80,000,” said the Vice President of Clinical Operations of a west coast pharmaceutical company. “Our CRO quickly agreed that the change made sense and adjusted their fees accordingly.”

About ClearTrial

ClearTrial is a leading provider of Clinical Trial Operations Planning (CTOP) software. ClearTrial’s software helps pharmaceutical, biotechnology, medical device companies and CROs expedite the clinical development process without sacrificing quality of results. The company’s software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit ClearTrial. (http://www.cleartrial.com)

ClearTrial®, ClearTrial® Plan, the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Other product names mentioned in this release are hereby acknowledged as registered trademarks of their respective owners.

###